RIKEN Center for Life Science Technologies

About CLST

Idea
greeting

Jobs at CLST

Access

Contact us

Links

Labs

Labs & Program

Center Director's Strategic Program RIKEN CLST-JEOL Collaboration Center

Publications

FANTOM

Technologies & Facilities

Technologies of CLST

Service of CLST

Radiosynthesis Database of PET Probes

Topics

  • Research

    Latest publications from CLST.
     

  • News

    Awards, agreements, and other news.

  • Events

    Upcoming and past events including seminars, symposiums, open days.

For Public

To let you know about our research, this area contains 4 types of information about CLST; “Article”, “Videos”, “Event” and “Study”.
At “Article”, you can read articles on interviews and lectures, and you can enjoy the videos about CLST at “Videos”. If you want to meet and talk directly with the researcher, “Visit” give you some information of such events. You can find more difficult contents to know about our research deeply at “Study”.
  • Article
  • Event
  • Videos
  • Study

Labs & Technologies

Drug Discovery Imaging Platform Unit

* Due to the reorganization starting as new centers in April 2018, The research activities of this laboratory are handed over to the Center for Biosystems Dynamics Research. As for the latest information, please see the following URL below.
> The webpage of Laboratory for Pathophysiological and Health Science, Center for Biosystems Dynamics Research

Unit Leader
Yasuyoshi Watanabe  M.D.,Ph.D

6-7-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan
Tel: +81-78-304-7101

3_7_watanabe.png

Research Area

The Drug Discovery Imaging Platform Unit is advancing in vivo pharmacokinetic research of monkeys, marmosets, rats, mice, rabbits, and humans by utilizing molecular imaging technology focused on positron emission tomography (PET). Labeling technologies for molecular imaging probes guarantee in vivo observation time and improve tracing after metabolic breakdown. Also, with a view to clinical studies of microdoses, we aim to build new drug discovery processes, developing labeling and probes for drug candidate compounds, as well as utilizing mice-to-human streamlined molecular imaging techniques.

Main Publications List

1

Exploration of Antiemetics for Osteoporosis Therapy-Induced Nausea and Vomiting Using PET Molecular Imaging Analysis to Gastrointestinal Pharmacokinetics

Shingaki T, Katayama Y, Nakaoka T, Takashima T, Onoe K, Okauchi T, Hayashinaka E, Wada Y, Cui Y, Watanabe Y.
Pharm Res., 33(5), 1235-1248 (2016).
2

Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer’s disease model mice.

Shukuri M, Mawatari A, Ohno M, Suzuki M, Doi H, Watanabe Y, Onoe H.
J Nucl Med, 57(2), 291-296 (2016).
3

Visualization of drug translocation in the nasal cavity and pharmacokinetic analysis on nasal drug absorption using positron emission tomography in the rat

Shingaki T, Katayama Y, Nakaoka T, Irie S, Onoe K, Okauchi T, Hayashinaka E, Yamaguchi M, Tanki N, Ose T, Hayashi T, Wada Y, Furubayashi T, Cui Y, Sakane T, Watanabe Y
Eur J Pharm Biopharm.,(99), 45-53 (2015).
4

Ni/Cu-Catalyzed Defluoroborylation of Fluoroarenes for Diverse C-F Bond Functionalizations

Niwa T, Ochiai H, Watanabe Y, Hosoya T
J Am Chem Soc, 137(45), 14313-14318 (2015).
5

Quantitative evaluation of mMate1 function based on minimally invasive measurement of tissue concentration using PET with [11C]Metformin in mouse.

Shingaki T, Hume WE, Takashima T, Katayama Y, Okauchi T, Hayashinaka E, Wada Y, Cui Y, Kusuhara H, Sugiyama Y, Watanabe Y.
Pharm Res, in press, (2015).
6

[11C]Cetrozole: an Improved C-[11C]Methylated PET Probe for Aromatase Imaging in the Brain.

Takahashi K, Hosoya T, Onoe K, Doi H, Nagata H, Hiramatsu T, Li XL, Watanabe Y, Wada Y, Takashima T, Suzuki M, Onoe H, Watanabe Y.
J Nucl Med, 55(5), 852-857 (2014).
7

PET Imaging Analysis with 64Cu in Disulfiram Treatment for Aberrant Copper Bio-distribution in Menkes Disease Mouse Model

Nomura S, Nozaki S, Hamazaki T, Takeda T, Ninomiya E, Kudo S, Hayashinaka E, Wada Y, Hiroki T, Fujisawa C, Kodama H, Shintaku H, Watanabe Y.
J Nucl Med, 55(5), 845-851 (2014).
8

Quantitative evaluation of the improvement in the pharmacokinetics of a nucleic acid drug delivery system by dynamic PET imaging with F-18-incorporated oligodeoxynucleotides

Mukai H, Ozaki D, Cui Y, Kuboyama T, Yamato-Nagata H, Onoe K, Takahashi M, Wada Y, Imanishi T, Kodama T, Obika S, Suzuki M, Doi H, Watanabe Y.
J Control Release, 180, 92-99 (2014).
9

The synthesis and biodistribution of [C-11]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo

Hume WE, Shingaki T, Takashima T, Hashizume Y, Okauchi T, Katayama Y, Hayashinaka E, Wada Y, Kusuhara H, Sugiyama Y, Watanabe Y.
Bioorg Med Chem, 21(24), 7584-7590 (2013).

Member  *concurrent

  • Yasuyoshi Watanabe

    Unit Leader

  • Yasuhiro Wada

    Senior Technical Scientist*

  • Yousuke Kanayama

    Research Scientist*

  • Satoshi Nozaki

    Research Scientist*

  • Kenichi Kaneko

    Research Scientist

  • Takayoshi Nakaoka

    Research Scientist

  • Satsuki Irie

    Technical Staff I

  • Natsumi Otsuka

    Temporary Staffing

  • Naomi Okabe

    Assistant

  • Yoko Nagatomo

    Assistant

CLST was reorganized into three centers according to the RIKEN 4th Medium-Term Plan from April 1, 2018. For the latest information of Drug Discovery Imaging Platform Unit, please visit the following websites.


> The webpage of Laboratory for Pathophysiological and Health Science, Center for Biosystems Dynamics Research [http://www.bdr.riken.jp/en/research/labs/watanabe-y-health/index.html]


> If you continue to browse this site, click here.